Wegovy: Why half of people who take it stop taking it within a year, and what happens when they stop taking it

While the new generation of anti-obesity drugs, known as GLP-1 receptor agonists, proves effective, long-term adherence remains a challenge. A recent study in the “Obesity” journal reveals that only 44% of individuals using weight-loss medications continue after three months, dropping to 19% after a year. Enhanced adherence, as seen with medications like Wegovy, results in… Continue reading Wegovy: Why half of people who take it stop taking it within a year, and what happens when they stop taking it

en_USEnglish